GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
7FEM | P0DTC2 | SARS-CoV-2 B.1.1.7 S-ACE2 complex | |
7FEM | Q9BYF1 | SARS-CoV-2 B.1.1.7 S-ACE2 complex | |
9FGR | P0DTC2 | SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv76-77 (focused refinement) | |
9FGR | 9FGR | SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv76-77 (focused refinement) | |
9FGS | P10104 | SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv41N (focused refinement) | |
9FGS | P0DTC2 | SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv41N (focused refinement) | |
9FGS | 9FGS | SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv41N (focused refinement) | |
7WZ2 | P0DTC2 | SARS-CoV-2 (D614G) Spike trimer | |
9FGU | P10104 | SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv76-77 (focused refinement) | |
9FGU | P0DTC2 | SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv76-77 (focused refinement) | |
9FGU | 9FGU | SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv76-77 (focused refinement) | |
9FGT | P10104 | SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv76 (focused refinement) | |
9FGT | P0DTC2 | SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv76 (focused refinement) | |
9FGT | 9FGT | SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv76 (focused refinement) | |
6NB7 | P59594 | SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2) | Spike glycoprotein, S230 heavy chain, S230 light chain |
6NB7 | 6NB7 | SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2) | Spike glycoprotein, S230 heavy chain, S230 light chain |
6NB6 | P59594 | SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1) | Spike glycoprotein, S230 heavy chain, S230 light chain |
6NB6 | 6NB6 | SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1) | Spike glycoprotein, S230 heavy chain, S230 light chain |
7L3N | P0DTC2 | SARS-CoV 2 Spike Protein bound to LY-CoV555 | Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain |
7L3N | 7L3N | SARS-CoV 2 Spike Protein bound to LY-CoV555 | Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain |
7FDG | Q9BYF1 | SARS-COV-2 Spike RBDMACSp6 binding to hACE2 | |
7FDG | P0DTC2 | SARS-COV-2 Spike RBDMACSp6 binding to hACE2 | |
7FDK | Q8R0I0 | SARS-COV-2 Spike RBDMACSp36 binding to mACE2 | |
7FDK | P0DTC2 | SARS-COV-2 Spike RBDMACSp36 binding to mACE2 | |
7FDI | Q9BYF1 | SARS-COV-2 Spike RBDMACSp36 binding to hACE2 | |
7FDI | P0DTC2 | SARS-COV-2 Spike RBDMACSp36 binding to hACE2 | |
7FDH | Q9BYF1 | SARS-COV-2 Spike RBDMACSp25 binding to hACE2 | |
7FDH | P0DTC2 | SARS-COV-2 Spike RBDMACSp25 binding to hACE2 | |
6CS1 | P59594 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CS1 | D9IEJ2 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CS0 | P59594 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CS0 | D9IEJ2 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CRZ | P59594 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRZ | D9IEJ2 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRX | P59594 | SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CRX | D9IEJ2 | SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CRW | P59594 | SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation | Spike glycoprotein,Envelope glycoprotein |
6CRW | D9IEJ2 | SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation | Spike glycoprotein,Envelope glycoprotein |
6CRV | P59594 | SARS Spike Glycoprotein, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRV | D9IEJ2 | SARS Spike Glycoprotein, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CS2 | P59594 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CS2 | D9IEJ2 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CS2 | Q9BYF1 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
8A99 | P0DTC2 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | 8A99 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | P0DTC2 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | 8A99 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A95 | P0DTC2 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A95 | 8A95 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A95 | P0DTC2 | SARS Cov2 Spike RBD in complex with Fab47 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024